NCT04637217

Brief Summary

Using Optical Coherence Tomography and ImageJ software the investigators will analyze retinal and choroidal vascular changes and their impact on retinal layers among patients with diabetes without retinopathy and patients with diabetes and retinopathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
Last Updated

November 19, 2020

Status Verified

November 1, 2020

Enrollment Period

1 year

First QC Date

November 12, 2020

Last Update Submit

November 18, 2020

Conditions

Keywords

optical coherence tomographychoroidouter retina

Outcome Measures

Primary Outcomes (2)

  • Correlation between choroid and outer retina using SD-OCT- based binarization technique

    starting from EDI-OCT scans the investigators will analyze choroidal parameters such as Luminal area, Stromal area, Total choroidal area, Chorodial vascularity index and correlate them with retinal pigment epithelium (RPE),outer nuclear layer(ONL) and photoreceptors' thickness (PR)

    2018-2019

  • Correlation between neurodegeneration and retinal vessels characteristics

    using full width at half maximum method, the investigators will measure peripapillary arteries and veins' diameters, their wall thickness and correlate them with RNFL and ganglion cell layer(GCL) thickness

    2018-2019

Secondary Outcomes (4)

  • Correlation between choroidal parameters and their influence on Best corrected visual acuity(BCVA)

    2018-2019

  • Correlation between renal function and choroidal parameters

    2018-2019

  • Correlation between sistemic factors and choroidal parameters

    2018-2019

  • Correlation between choroidal parameters and diabetes control

    2018-2019

Study Arms (3)

Control

Diagnostic Test: Optical Coherence Tomography

Diabetes mellitus without Diabetic Retinopathy

Diagnostic Test: Optical Coherence Tomography

Diabetes mellitus with Diabetic Retinopathy

Diagnostic Test: Optical Coherence Tomography

Interventions

Spectral Domain Optical Coherence Tomography(SD-OCT) examination will be performed for every patient: posterior pole scan, EDI-OCT(enhanced depth imaging-OCT) and peripapillary RNFL(retinal nerve fiber layer)

ControlDiabetes mellitus with Diabetic RetinopathyDiabetes mellitus without Diabetic Retinopathy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants were recruited between July 2018 and July 2019 at Department of Ophthalmology, Emergency County Hospital Cluj, Romania. Healthy subjects were recruited from patients scheduled for routine ocular examination at Department of Ophthalmology, Emergency County Hospital Cluj, Romania

You may qualify if:

  • history of type 1DM for more than 1 year
  • history of type 2 DM for more than 3 months
  • diagnosis of no DR or mild Non-proliferative diabetic retinopathy(NPDR)

You may not qualify if:

  • DR with more than NPDR ,
  • Diabetic macular oedema,
  • media opacities such as corneal or lens opacities that could preclude appropriate OCT imaging,
  • presence of other retinal diseases such as Age-related macular degeneration, Vitreo-macular traction, Macular hole, Epiretinal membrane, Retinal vein occlusion, Macular scars,
  • Glaucoma, Optic neuropathies or Neurodegenerative diseases,
  • history of ocular trauma,
  • Refractive errors of more than ±6 diopters (spherical equivalent),
  • previous ocular surgery, focal laser, panretinal photocoagulation or anti-VEGF intravitreal injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Medicine and Pharmacy " Iuliu Hatieganu"

Cluj-Napoca, Romania

Location

MeSH Terms

Conditions

Diabetic RetinopathyNerve Degeneration

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Ioana Damian, MD

    Iuliu Hatieganu University of Medicine and Pharmacy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 12, 2020

First Posted

November 19, 2020

Study Start

July 1, 2018

Primary Completion

July 1, 2019

Study Completion

July 1, 2019

Last Updated

November 19, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After the papers will be published.

Locations